Back to search

Article

How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent Expiry

2026-03-04

Abstract excerpt

<h4>Objectives</h4> To estimate potential launch prices of generic semaglutide following patent expiry from 2026 and to quantify the global obesity and type 2 diabetes (T2DM) burden in countries where generic access may become possible. <h4>Methods</h4> We used World Bank population data and World Obesity and Diabetes Atlas prevalence estimates to calculate obesity and T2DM burden in countries where semaglutide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8dae3a80-2275-5954-9c56-aa04a93811ad
DOI
10.64898/2026.03.04.26347508
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent ExpiryDOI 10.64898/2026.03.04.26347508
Estimated Costs of Production Compared with National Prices, for Drugs to Treat Clinical ObesitySemantic proximity
Are Semaglutide and Tirzepatide Cost-Effective for Weight Management? A Systematic Review and Meta-analysisSemantic proximity
Guiding the willingness to pay for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome using a cost-based-plus pricing frameworkSemantic proximity
Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity
Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsSemantic proximity
A Case of Excessive, Opportunistic Price Increase of a Generic Oncology DrugSemantic proximity
Access to Essential Medicines for Diabetes Care: Availability, Price, and Affordability in Central EthiopiaSemantic proximity
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Semantic proximity
Applying the Efficiency Frontier to Inform Value-Based Pricing for Gaucher Disease Therapies in BrazilSemantic proximity
Evolving Health Policies and Pricing Dynamics in U.S. Multiple Sclerosis Therapies: A Longitudinal Analysis with Policy ImplicationsSemantic proximity
Variation in price of cardiovascular and diabetes medicine in Indonesia, and relationship with quality: a mixed methods study in East JavaSemantic proximity
Methodological Challenges in Dutch HTA of Non-Oncological Orphan Drugs: A Retrospective Analysis and Price Comparison Using different Pricing ModelsSemantic proximity
Select a neighboring publication to make it the new centre.